GlassScriptPhysician profile
Benjamin J Steinberg
NPI 1124280581
$5,585.95
in general payments reported to CMS, 2019-2025
27 companies · $109 in 2025
The $109 reported for 2025 was less than what a typical Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) provider received nationally (typical 2025 total: $413).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,388 · 2020: $499 · 2021: $406 · 2022: $759 · 2023: $989 · 2024: $1,435 · 2025: $109.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,665 · Travel and Lodging: $814 · Education: $54.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,665.02 |
| Travel and Lodging | $813.77 |
| Education | $54.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $954.58 | 2023-2025 | Gemtesa |
| Medical Device Business Services, INC. | $878.41 | 2024 | Harmonic |
| Boston Scientific Corporation | $697.24 | 2019-2024 | Upsylon, Advantage System |
| Laborie Medical Technologies Corp. | $534.92 | 2019-2024 | Eclipse |
| Astellas Pharma US INC | $481.02 | 2019-2023 | Myrbetriq |
| Medtronic, INC. | $318.28 | 2021-2023 | Interstim |
| Urovant Sciences INC | $301.90 | 2022 | |
| Axonics, INC. | $286.54 | 2020-2024 | Axonics |
| Therapeuticsmd, INC. | $182.25 | 2019 | |
| Stryker Corporation | $149.38 | 2022 | |
| Medtronic USA, INC. | $131.27 | 2019 | |
| Contura, INC. | $130.02 | 2020 | |
| Allergan, INC. | $119.15 | 2019-2021 | |
| Ferring Pharmaceuticals INC. | $75.77 | 2019 | |
| Ethicon US, LLC | $70.47 | 2024 | Stratafix, Vistaseal |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $46.47 | 2023-2025 | Orilissa |
| Pfizer INC. | $43.50 | 2019-2020 | |
| Intuitive Surgical, INC. | $33.78 | 2022-2025 | |
| 180 Medical, INC. | $25.56 | 2022 | |
| Caldera Medical, INC | $24.57 | 2021 | |
| Meditrina | $18.83 | 2025 | |
| Rochester Medical Corporation | $17.70 | 2019 | |
| Celularity INC. | $15.00 | 2019 | |
| Olympus America INC. | $14.68 | 2019 | |
| Amag Pharmaceuticals, INC. | $14.04 | 2019 | |
| Sagent Pharmaceuticals | $12.57 | 2021 | |
| Mayne Pharma Commercial LLC | $8.05 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benjamin Steinberg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.